T

he field of organs-on-chips scored an early victory Tuesday: Boston organ-on-a-chip startup Emulate has partnered with the Food and Drug Administration to test whether the technology works for toxicity screening purposes.

But this is just an early gambit into the wider world of organs-on-chips — since tox screening accounts for just 10 percent of the preclinical testing typically conducted on animals, said Dr. Thomas Hartung, who is director of the Center for Alternatives to Animal Testing at Johns Hopkins University.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Complete metabolic profile and other laboratory test in real-time not drawing blood or urine through the integment…

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.

X